← All candidates
One insider buy in the last year — $227.0K in all.
38 filings on record.
ARVNARVINAS, INC.
NasdaqGS · Healthcare · $518.11M
$8.45
-2.99% · Sep 11
One insider buy in the last year — $227.0K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy● 16 sells◆ 9 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$518.11M
Float
55.8M
86% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
5.8
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Morrison Briggs
Bought $227.0K on Sep 22 — 30,000 sh @ $7.57, held direct, 40% of their stake.
First Form 4 on file
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
33 more transactions on Pro →Context
Wall St
$15.00 avg target
+77.5% vs today · 16 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q2 '26$2.58 act+$2.86
Q1 '26−$0.90 act+$0.06
Q4 '25−$1.10 act−$0.53
Q3 '25−$0.48 act+$0.26
The file stays open
38 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice